Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Ltd ADR (NY: TEVA )

8.340 +0.060 (+0.72%)
Streaming Delayed Price Updated: 1:30 PM EDT, May 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,708,711
Open 8.230
Bid (Size) 8.330 (111)
Ask (Size) 8.340 (20)
Prev. Close 8.280
Today's Range 8.210 - 8.430
52wk Range 7.230 - 11.54
Shares Outstanding 1,110,352,397
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
 
Via Benzinga
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) stock, according to BofA Securities. 
Via Benzinga

Performance

YTD
+0.12%
+0.12%
1 Month
-17.51%
-17.51%
3 Month
-1.77%
-1.77%
6 Month
-8.95%
-8.95%
1 Year
-21.84%
-21.84%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022
Via Benzinga
United Kingdom first to grant licence for Teva’s ophthalmology biosimilar Ongavia (ranibizumab)▼
From Teva Pharmaceutical Industries Limited
Via Business Wire
Why Generic Drugs Giant Teva Pharmaceutical Just Cut Its 2022 Outlook
Via Investor's Business Daily
FDA Rejects Teva - MedinCell's Schizophrenia Candidate
Via Benzinga
Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Association Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces New Findings Highlighting Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Address Asthma Treatment Challenges
From Teva Pharmaceutical Industries Limited
Via Business Wire
4 Analysts Have This to Say About Teva Pharmaceutical Indus
Via Benzinga
Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society 2022 Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
Via Benzinga
Teva Publishes 2021 ESG Progress Report, Showcasing Further Integration of ESG Into Business, Robust Targets and Strengthened ESG Governance Structure
From Teva Pharmaceutical Industries Limited
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022
Via Benzinga
Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise
Via Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Via Benzinga
Recap: Teva Pharmaceutical Q1 Earnings
Via Benzinga
Teva Reports First Quarter 2022 Financial Results
From Teva Pharmaceutical Industries Limited
Via Business Wire
Earnings Scheduled For May 3, 2022
Via Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Via Benzinga
Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispute
From Teva Pharmaceutical Industries Limited
Via Business Wire
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Via Benzinga
JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters
Via Benzinga
The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus' COVID-19 Vaccine Trial Data, FDA Rejects Teva's Schizophrenia Med, Otonomy Aces Hearing Loss Study
Via Benzinga
Teva and MedinCell Receive Complete Response Letter for TV-46000/mdc-IRM
From Teva Pharmaceutical Industries Limited
Via Business Wire
What Were Your Best And Worst Stock Buys? What Does The Zinger Nation Think?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.